We are chemists, physicists, mathematicians, engineers, biologists who work alongside to design bionic units that mimic specific biological functions and/or introduce operations that do not exist in Nature. We apply … Read more
IBEC group leader Silvia Muro has been granted funding in MINECO’s ‘Explora Ciencia’ and ‘Explora Tecnología’ 2017 call.It’s the first competitive grant for Silvia and her group since she joined IBEC at the end of 2017, and one of only 97 research projects to be financed out of the 1594 applications submitted – a success rate of only 6%.
The project, ‘Controlling the differential transport of therapeutic cargoes into versus across the BBB (BBB2GATE)’ will aim to develop drug vehicles that can cross the blood-brain barrier using the natural routes that the body’s substances use to circumvent this obstruction.
The Institute for Bioengineering of Catalonia (IBEC), a cutting-edge research center based in Barcelona, is looking for a Project Manager in Research. His/her role will be to oversee and manage the research projects of several research lines, liaising with other sites and institutions across Spain and Europe.
This position is supported by the Spanish Ministry of Economy and Competitiveness within the Severo Ochoa Centres of Excellence Initiative.
Collaborating IBEC groups have published a study in Nature Communications that reveals that electron transfer can take place while a protein is approaching its partner site, and not only when the proteins are engaged, as was previously thought. The results open up a new way of thinking about how proteins interact, and can have implications in a better understanding of many processes – such as photosynthesis, respiration and detoxification – in which electron transfer plays an important role.
The relocation of an electron from one chemical entity to another – electron transfer (ET) – doesn’t happen passively: electrons are carried individually by redox proteins.
The biotechnology company Iproteos, IBEC and the Vall d’Hebron Research Institute (VHIR) are set to develop an innovative treatment to slow down, stop and even reverse the growth of solid tumors, which represent more than 90% of cancer cases.It’s a family of peptidomimetic drugs based on a totally new anti-tumor action mechanism, the result of several years of research by Pere Roca-Cusachs’ group at IBEC.
The Translational Research Group on Cancer in Children and Teenagers at VHIR will evaluate candidate drugs, developed with Iproteos’ IPROTech technology, in pediatric tumours in vitro and in vivo.
Application Deadline: 20/12/2018
Ref: LA-SS
The nanodevices group at the Institute for Bioengineering of Catalonia (IBEC) is looking for a Laboratory Technician to support scientist in the development of new fabrication and functionalization techniques.
Application Deadline: 31/12/2018
Ref: TL-XT
The Integrative cell and tissue dyamics group at the Institute for Bioengineering of Catalonia (IBEC) is looking for Laboratory Technician candidate to participate on the development of a traction microscopy in three-dimensional epithelia. The contract will be within the framework of ERC project TensionControl, whose objective is to provide a multiscale understanding of tension regulation within epithelial cell monolayers.
Application Deadline: 20/12/2018
Ref: PD-PG
The Nanoprobes and Nanoswitches Group is looking for a postdoctoral researcher to develop light-regulated drugs to control brain waves. The contract will be within the framework of the project Technologies Emergent (CECH) and of the 2017-SGR-1442 (AGAUR).
An article about the EU-funded project Plantoid – which aims to design subterranean robots for soil exploration and monitoring that draw inspiration from plants – has appeared on the European … Read more
